Asia On The Move: People News From GSK, Eisai And Others
This article was originally published in PharmAsia News
Executive Summary
GSK’s Japan subsidiary appoints a new executive director; Eisai has a new general manager for China; WuXi appoints an independent board director for audit; and Chugai enhances compliance governance.